EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacterial heterozygosity promotes survival under multidrug selection

Shraddha Shitut, Thomas van Dijk, Dennis Claessen, Daniel Rozen

Current Biology · 2025

DOI: 10.1016/j.cub.2025.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Biology, 2025. Verfasst von Shraddha Shitut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Origins Centre, Groningen, the Netherlands; Institute of Biology, Leiden University, Sylviusweg 72, 2333 Leiden, the Netherlands. Electronic address:…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Heterozygote, Streptomycetaceae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although bacterial cells typically contain a single chromosome, some species are naturally polyploid and carry multiple copies of their chromosome. Polyploid chromosomes can be identical or heterogeneous, the latter giving rise to bacterial heterozygosity. Although the benefits of heterozygosity are well studied in eukaryotes, its consequences in bacteria are less understood. Here, we examine this question in the context of antibiotic resistance to understand how bacterial genomic heterozygosity affects bacterial survival. Using a cell-wall-deficient model system in the actinomycete Kitasatospora viridifaciens, we found that heterozygous cells that contain different chromosomes expressing different antibiotic resistance markers persist across a broad range of antibiotic concentrations. Recombinant cells containing the same resistance genes on a single chromosome also survive these conditions, but these cells pay a significant fitness cost due to the constitutive expression of these genes. By contrast, heterozygous cells can mitigate these costs by flexibly adjusting the ratio of their different chromosomes, thereby allowing rapid responses in temporally and spatially variable environments. Our results provide evidence that bacterial heterozygosity can increase adaptive plasticity in bacterial cells in a similar manner to the evolutionary benefits provided by multicopy plasmids in bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug Resistance, BacterialHeterozygoteStreptomycetaceaeCell WallChromosomes, BacterialGene Expression Regulation, BacterialSelection, Genetic

Stichwörter der Autor:innen

L-form bacteriaadaptive plasticityantibiotic resistancebacterial heterozygositybacterial polyploidy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Origins Centre, Groningen, the Netherlands; Institute of Biology, Leiden University, Sylviusweg 72, 2333 Leiden, the Netherlands. Electronic address: shraddha.shitut@gmail.com.
  • Institute of Biology, Leiden University, Sylviusweg 72, 2333 Leiden, the Netherlands.
  • Institute of Biology, Leiden University, Sylviusweg 72, 2333 Leiden, the Netherlands. Electronic address: d.e.rozen@biology.leidenuniv.nl.

Förderung

  • Dutch Research Council

Zitieren

APA

Shitut, S., van Dijk, T., Claessen, D., & Rozen, D. (2025). Bacterial heterozygosity promotes survival under multidrug selection. Current Biology. https://doi.org/10.1016/j.cub.2025.02.012

Vancouver

Shitut S, van Dijk T, Claessen D, Rozen D. Bacterial heterozygosity promotes survival under multidrug selection. Current Biology. 2025. doi:10.1016/j.cub.2025.02.012

BibTeX
@article{Shitut2025,
  author = {Shitut, Shraddha and van Dijk, Thomas and Claessen, Dennis and Rozen, Daniel},
  title = {Bacterial heterozygosity promotes survival under multidrug selection},
  journal = {Current Biology},
  year = {2025},
  doi = {10.1016/j.cub.2025.02.012}
}
Kostenlos starten →